Le Lézard11 小时
New data for emapalumab in the treatment of macrophage activation syndrome to be presented ...
Sobi® (STO: SOBI) today announced that new research showing the effect of emapalumab in patients with macrophage activation syndrome (MAS) in Still's disease, including systemic juvenile idiopathic ...
What Is Causing Your Eczema, and What Experts Say You Should Do to Calm Flare-Ups
Don’t scratch. Plus, the OTC and DIY treatments that help, and what you should avoid.Eczema patches can show up at any time, ...
They're middle-class and insured. Childbirth still left them with crippling debt.
Some middle-class families with private insurance have been left behind by recent health care reforms, putting them at risk ...
Mamamia on MSN19 小时
'As a dermatologist, I've been using these beauty secrets for decades. I refuse to gatekeep ...
In an Instagram post titled, 'Ageing secrets I refuse to gatekeep as a 40-year-old dermatologist', dermatologist Dr Shereene Idriss from the US ( @shereeneidriss on Instagram), listed all of the ...
Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH ...
Bill Sibold, Chief Executive Officer of Madrigal, stated, “This will be the first AASLD Liver Meeting following the approval of Rezdiffra earlier this year, and the entire NASH community feels ...